Norris Medicines Ltd — Important, 12-01-2026: Company Update

NORRIS MEDICINES LTD has confirmed compliance with share dematerialization procedures for the quarter. Its Registrar and Transfer Agent ensured all shares received for electronic conversion were properly processed, accepted or rejected, and subsequently listed on stock exchanges. Physical share certificates were cancelled, and shareholder records updated within required timelines. This routine update assures investors that the company maintains robust processes for managing electronic share transfers and shareholder records.